ArticleJournal of medical biochemistry2017

ADMA, SDMA and L-arginine may be Novel Targets in Pharmacotherapy for Complications due to Cardiopulmonary Bypass.

Aydın Kahraman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.